{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:11:16Z","timestamp":1793988676762,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013465","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["21611"],"award-info":[{"award-number":["21611"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["21611"],"award-info":[{"award-number":["21611"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GUP13012"],"award-info":[{"award-number":["GUP13012"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009879","name":"Regione Emilia-Romagna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Facioscapulohumeral muscular dystrophy (FSHD) is a myopathy with prevalence of 1 in 20,000. Almost all patients affected by FSHD carry deletions of an integral number of tandem 3.3 kilobase repeats, termed D4Z4, located on chromosome 4q35. Assessment of size of D4Z4 alleles is commonly used for FSHD diagnosis. However, the extended molecular testing has expanded the spectrum of clinical phenotypes. In particular, D4Z4 alleles with 9\u201310 repeat have been found in healthy individuals, in subjects with FSHD or affected by other myopathies. These findings weakened the strict relationship between observed phenotypes and their underlying genotypes, complicating the interpretation of molecular findings for diagnosis and genetic counseling. In light of the wide clinical variability detected in carriers of D4Z4 alleles with 9\u201310 repeats, we applied a standardized methodology, the Comprehensive Clinical Evaluation Form (CCEF), to describe and characterize the phenotype of 244 individuals carrying D4Z4 alleles with 9\u201310 repeats (134 index cases and 110 relatives). The study shows that 54.5% of index cases display a classical FSHD phenotype with typical facial and scapular muscle weakness, whereas 20.1% present incomplete phenotype with facial weakness or scapular girdle weakness, 6.7% display minor signs such as winged scapula or hyperCKemia, without functional motor impairment, and 18.7% of index cases show more complex phenotypes with atypical clinical features. Family studies revealed that 70.9% of relatives carrying 9\u201310 D4Z4 reduced alleles has no motor impairment, whereas a few relatives (10.0%) display a classical FSHD phenotype. Importantly all relatives of index cases with no FSHD phenotype were healthy carriers. These data establish the low penetrance of D4Z4 alleles with 9\u201310 repeats. We recommend the use of CCEF for the standardized clinical assessment integrated by family studies and further molecular investigation for appropriate diagnosis and genetic counseling. Especially in presence of atypical phenotypes and\/or sporadic cases with all healthy relatives is not possible to perform conclusive diagnosis of FSHD, but all these cases need further studies for a proper diagnosis, to search novel causative genetic defects or investigate environmental factors or co-morbidities that may trigger the pathogenic process. These evidences are also fundamental for the stratification of patients eligible for clinical trials. Our work reinforces the value of large genotype\u2013phenotype studies to define criteria for clinical practice and genetic counseling in rare diseases.<\/jats:p>","DOI":"10.1038\/s41598-020-78578-7","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T06:09:12Z","timestamp":1607580552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Large genotype\u2013phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Giulia","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Govi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Moggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scarlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano C.","family":"Previtali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Maria","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Telese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Berardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Tomelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Tupler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"78578_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1399-0004.2009.01158.x","volume":"75","author":"ML Mostacciuolo","year":"2009","unstructured":"Mostacciuolo, M. L. et al. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet 75, 550\u2013555 (2009).","journal-title":"Clin Genet"},{"key":"78578_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","volume":"83","author":"JC Deenen","year":"2014","unstructured":"Deenen, J. C. et al. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 83, 1056\u20131059 (2014).","journal-title":"Neurology"},{"key":"78578_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0960-8966(91)90094-9","volume":"1","author":"GW Padberg","year":"1991","unstructured":"Padberg, G. W., Lunt, P. W., Koch, M. & Fardeau, M. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1, 231\u2013234 (1991).","journal-title":"Neuromuscul Disord"},{"key":"78578_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/practneurol-2015-001353","volume":"16","author":"K Mul","year":"2016","unstructured":"Mul, K. et al. What\u2019s in a name? The clinical features of facioscapulohumeral muscular dystrophy. Pract Neurol 16, 201\u2013207 (2016).","journal-title":"Pract Neurol"},{"key":"78578_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"R Tawil","year":"2015","unstructured":"Tawil, R. et al. Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular and Electrodiagnostic Medicine. Neurology 85, 357\u2013364 (2015).","journal-title":"Neurology"},{"issue":"19","key":"78578_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1212\/WNL.0000000000007446","volume":"92","author":"NE Johnson","year":"2019","unstructured":"Johnson, N. E. & Statland, J. M. FSHD1 or FSHD2: that is the question: the answer: it\u2019s all just FSHD. Neurology 92(19), 881\u2013882 (2019).","journal-title":"Neurology"},{"key":"78578_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ng0992-26","volume":"2","author":"C Wijmenga","year":"1992","unstructured":"Wijmenga, C. et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2, 26\u201330 (1992).","journal-title":"Nat Genet"},{"issue":"2","key":"78578_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0960-8966(98)00012-1","volume":"8","author":"P Lunt","year":"1998","unstructured":"Lunt, P. 44th ENMC international workshop: facioscapulohumeral muscular dystrophy: molecular studies: 19\u201321 July 1996, Naarden, The Netherlands. Neuromuscul Disord 8(2), 126\u2013130 (1998).","journal-title":"Neuromuscul Disord"},{"key":"78578_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/hmg\/ddu486","volume":"24","author":"RJ Lemmers","year":"2015","unstructured":"Lemmers, R. J. et al. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Hum Mol Genet 24, 659\u2013669 (2015).","journal-title":"Hum Mol Genet"},{"key":"78578_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1212\/WNL.43.2.345","volume":"43","author":"R Tawil","year":"1993","unstructured":"Tawil, R. et al. Extreme variability of expression in monozygotic twins with FSH muscular dystrophy. Neurology 43, 345\u2013348 (1993).","journal-title":"Neurology"},{"key":"78578_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jmg.35.9.778","volume":"35","author":"R Tupler","year":"1998","unstructured":"Tupler, R. et al. Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. J Med Genet 35, 778\u2013783 (1998).","journal-title":"J Med Genet"},{"key":"78578_CR12","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","volume":"136","author":"G Ricci","year":"2013","unstructured":"Ricci, G. et al. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain 136, 3408\u20133417 (2013).","journal-title":"Brain"},{"issue":"5","key":"78578_CR13","doi-asserted-by":"publisher","first-page":"e204040","DOI":"10.1001\/jamanetworkopen.2020.4040","volume":"3","author":"L Ruggiero","year":"2020","unstructured":"Ruggiero, L. et al. Phenotypic variability among Patients with D4Z4 reduced allele Facioscapulohumeral muscular dystrophy. JAMA Open Netw 3(5), e204040 (2020).","journal-title":"JAMA Open Netw"},{"key":"78578_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ana.410390610","volume":"39","author":"R Tawil","year":"1996","unstructured":"Tawil, R. et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39, 744\u2013748 (1996).","journal-title":"Ann Neurol"},{"key":"78578_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","volume":"77","author":"M Zatz","year":"1998","unstructured":"Zatz, M. et al. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet 77, 155\u2013161 (1998).","journal-title":"Am J Med Genet"},{"key":"78578_CR16","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1136\/jmg.2003.008755","volume":"41","author":"K Goto","year":"2004","unstructured":"Goto, K., Nishino, I. & Hayashi, Y. K. Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy. J Med Genet 41, e12 (2004).","journal-title":"J Med Genet"},{"key":"78578_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2174\/1566524014666141010155054","volume":"14","author":"G Ricci","year":"2014","unstructured":"Ricci, G., Zatz, M. & Tupler, R. Facioscapulohumeral muscular dystrophy: more complex than it appears. Curr Mol Med 14, 1052\u20131068 (2014).","journal-title":"Curr Mol Med"},{"key":"78578_CR18","doi-asserted-by":"publisher","first-page":"e007798","DOI":"10.1136\/bmjopen-2015-007798","volume":"6","author":"A Nikolic","year":"2016","unstructured":"Nikolic, A. et al. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1\u20133 D4Z4 reduced alleles: experience of the FSHD Italian National Registry. BMJ Open 6, e007798 (2016).","journal-title":"BMJ Open"},{"issue":"12","key":"78578_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.nmd.2017.09.007","volume":"27","author":"RJM Goselink","year":"2017","unstructured":"Goselink, R. J. M. et al. Early onset facioscapulohumeral dystrophy\u2014a systematic review using individual patient data. Neuromuscul Disord 27(12), 1077\u20131083 (2017).","journal-title":"Neuromuscul Disord"},{"key":"78578_CR20","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/hmg\/9.19.2879","volume":"9","author":"PGM vanOverveld","year":"2000","unstructured":"vanOverveld, P. G. M. et al. Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity. Hum Mol Genet 9, 2879\u20132884 (2000).","journal-title":"Hum Mol Genet"},{"key":"78578_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.61.7.909","volume":"61","author":"M Wohlgemuth","year":"2003","unstructured":"Wohlgemuth, M. et al. Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles. Neurology 61, 909\u2013913 (2003).","journal-title":"Neurology"},{"key":"78578_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajhg.2012.02.019","volume":"90","author":"I Scionti","year":"2012","unstructured":"Scionti, I. et al. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 90, 628\u2013635 (2012).","journal-title":"Am J Hum Genet"},{"key":"78578_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJ Lemmers","year":"2012","unstructured":"Lemmers, R. J. et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 44, 1370\u20131374 (2012).","journal-title":"Nat Genet"},{"key":"78578_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ejhg.2014.191","volume":"23","author":"M Larsen","year":"2015","unstructured":"Larsen, M. et al. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifier of disease severity in FSHD1. Eur J Hum 23, 808\u2013816 (2015).","journal-title":"Eur J Hum"},{"key":"78578_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML van den Boogaard","year":"2016","unstructured":"van den Boogaard, M. L. et al. Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am J Hum Genet 98, 1020\u20131029 (2016).","journal-title":"Am J Hum Genet"},{"issue":"3","key":"78578_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/genes11030258","volume":"11","author":"V Salsi","year":"2020","unstructured":"Salsi, V., Magdinier, F. & Tupler, R. Does DNA methylation matter in FSHD?. Genes 11(3), 258 (2020).","journal-title":"Genes"},{"issue":"7","key":"78578_CR27","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3390\/ijms21072635","volume":"21","author":"A Nikolic","year":"2020","unstructured":"Nikolic, A. et al. Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies. Int J Mol Sci 21(7), 2635 (2020).","journal-title":"Int J Mol Sci"},{"key":"78578_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00415-003-1116-y","volume":"250","author":"M Butz","year":"2003","unstructured":"Butz, M. et al. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. J Neurol 250, 932\u2013937 (2003).","journal-title":"J Neurol"},{"key":"78578_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.nmd.2017.04.004","volume":"27","author":"K Mul","year":"2017","unstructured":"Mul, K. et al. 225th ENMC international workshop: a global FSHD registry framework, 18\u201320 November 2016, Heemskerk, The Netherlands. Neuromuscul Disord 27, 782\u2013790 (2017).","journal-title":"Neuromuscul Disord"},{"key":"78578_CR30","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00415-016-8123-2","volume":"263","author":"G Ricci","year":"2016","unstructured":"Ricci, G. et al. A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes. J Neurol 263, 1204\u20131214 (2016).","journal-title":"J Neurol"},{"key":"78578_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mus.21671","volume":"42","author":"C Lamperti","year":"2010","unstructured":"Lamperti, C. et al. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: the FSHD clinical score. Muscle Nerve 42, 213\u2013217 (2010).","journal-title":"Muscle Nerve"},{"key":"78578_CR32","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1002\/mus.880181319","volume":"2","author":"PW Lunt","year":"1995","unstructured":"Lunt, P. W. et al. Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy. Muscle Nerve 2, S103-109 (1995).","journal-title":"Muscle Nerve"},{"key":"78578_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/jmg.2006.042804","volume":"44","author":"NS Thomas","year":"2007","unstructured":"Thomas, N. S. et al. A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. J Med Genet 44, 215\u2013218 (2007).","journal-title":"J Med Genet"},{"key":"78578_CR34","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1212\/WNL.54.10.1927","volume":"54","author":"KJ Felice","year":"2000","unstructured":"Felice, K. J. et al. FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy. Neurology 54, 1927\u20131931 (2000).","journal-title":"Neurology"},{"key":"78578_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-08-045031-5.00013-X","volume":"101","author":"RW Orrell","year":"2011","unstructured":"Orrell, R. W. Facioscapulohumeral dystrophy and scapuloperoneal syndromes. Handb Clin Neurol 101, 167\u2013180 (2011).","journal-title":"Handb Clin Neurol"},{"key":"78578_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/ene.13509","volume":"25","author":"JJ He","year":"2018","unstructured":"He, J. J. et al. Clinical and genetic features of patients with facial-sparing facioscapulohumeral muscular dystrophy. Eur J Neurol 25, 356\u2013364 (2018).","journal-title":"Eur J Neurol"},{"key":"78578_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M","volume":"45","author":"E Ricci","year":"1999","unstructured":"Ricci, E. et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45, 751\u2013757 (1999).","journal-title":"Ann Neurol"},{"key":"78578_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nmd.2003.07.001","volume":"14","author":"MM Tonini","year":"2004","unstructured":"Tonini, M. M. et al. Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 14, 33\u201338 (2004).","journal-title":"Neuromuscul Disord"},{"key":"78578_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nmd.2011.11.001","volume":"22","author":"P Sakellariou","year":"2012","unstructured":"Sakellariou, P. et al. Mutation spectrum and phenotypic manifestation in FSHD Greek patients. Neuromuscul Disord 22, 339\u2013349 (2012).","journal-title":"Neuromuscul Disord"},{"key":"78578_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-014-0218-1","volume":"10","author":"E Salort-Campana","year":"2015","unstructured":"Salort-Campana, E. et al. Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study. Orphanet J Rare Dis 10, 2 (2015).","journal-title":"Orphanet J Rare Dis"},{"key":"78578_CR41","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.4103\/0366-6999.159336","volume":"128","author":"F Lin","year":"2015","unstructured":"Lin, F. et al. New insights into genotype-phenotype correlations in Chinese facioscapulohumeral muscular dystrophy: a retrospective analysis of 178 patients. Chin Med J (Engl) 128, 1707\u20131713 (2015).","journal-title":"Chin Med J (Engl)"},{"key":"78578_CR42","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.0000000000002217","volume":"85","author":"JM Statland","year":"2015","unstructured":"Statland, J. M. et al. Milder phenotype in facioscapulohumeral dystrophy with 7\u201310 residual D4Z4 repeats. Neurology 85, 2147\u20132150 (2015).","journal-title":"Neurology"},{"issue":"6","key":"78578_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/mus.26474","volume":"59","author":"G Ricci","year":"2019","unstructured":"Ricci, G. et al. Phenotype may predict the clinical course of facioscapolohumeralmuscular dystrophy. Muscle Nerve 59(6), 711\u2013713 (2019).","journal-title":"Muscle Nerve"},{"key":"78578_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10144-7","author":"L Vercelli","year":"2020","unstructured":"Vercelli, L., Mele, .F, Ruggiero, L. et al. A 5-year clinical follow-up study from the Italian National Registry for FSHD. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10144-7 (2020).","journal-title":"J Neurol"},{"key":"78578_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mus.21722","volume":"42","author":"M Kottlors","year":"2010","unstructured":"Kottlors, M. et al. Facioscapulohumeral muscular dystrophy presenting with isolated axial myopathy and bent spine syndrome. Muscle Nerve 42, 273\u2013275 (2010).","journal-title":"Muscle Nerve"},{"key":"78578_CR46","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/mus.24689","volume":"52","author":"PS Ghosh","year":"2015","unstructured":"Ghosh, P. S. & Milone, M. Camptocormia as presenting manifestation of a spectrum of myopathic disorders. Muscle Nerve 52, 1008\u20131012 (2015).","journal-title":"Muscle Nerve"},{"key":"78578_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awv332","volume":"139","author":"N Witting","year":"2016","unstructured":"Witting, N., Andersen, L. K. & Vissing, J. Axial myopathy: an overlooked feature of muscle diseases. Brain 139, 13\u201322 (2016).","journal-title":"Brain"},{"issue":"5","key":"78578_CR48","doi-asserted-by":"publisher","first-page":"e205004","DOI":"10.1001\/jamanetworkopen.2020.5004","volume":"3","author":"K Nguyen","year":"2020","unstructured":"Nguyen, K. & Robin, J. D. Facioscapulohumeral muscular dystrophy-a tale of heterogeneity and the power of clinical assessments. JAMA Netw Open 3(5), e205004 (2020).","journal-title":"JAMA Netw Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78578-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:25:16Z","timestamp":1670354716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78578"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78578-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21648"}}